KAS
CGTX icon

Kestra Advisory Services’s Cognition Therapeutics CGTX Stock Holding History

Kestra Advisory Services’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-155,934
Closed -$48.3K – 2915
2025
Q2 		$48.3K Sell
155,934
-21,500
-12% -$7.26K ﹤0.01% 2772
2025
Q1 		$74.7K Hold
177,434
– – ﹤0.01% 2621
2024
Q4 		$124K Sell
177,434
-11,000
-6% -$5.44K ﹤0.01% 2548
2024
Q3 		$88.3K Hold
188,434
– – ﹤0.01% 2479
2024
Q2 		$313K Sell
188,434
-11,000
-6% -$21.9K ﹤0.01% 2094
2024
Q1 		$363K Sell
199,434
-20,000
-9% -$41.3K ﹤0.01% 1870
2023
Q4 		$406K Buy
219,434
+40,650
+23% +$53.8K ﹤0.01% 1648
2023
Q3 		$257K Buy
178,784
+5,000
+3% +$7.83K ﹤0.01% 1771
2023
Q2 		$318K Buy
173,784
+78,784
+83% +$167K ﹤0.01% 1575
2023
Q1 		$188K Buy
95,000
+44,382
+88% +$84.6K ﹤0.01% 1860
2022
Q4 		$106K Buy
50,618
+35,618
+237% +$71.9K ﹤0.01% 2134
2022
Q3 		$29K Hold
15,000
– – ﹤0.01% 2053
2022
Q2 		$32K Sell
15,000
-223,666
-94% -$578K ﹤0.01% 2070
2022
Q1 		$656K Buy
238,666
+143,554
+151% +$553K 0.01% 1136
2021
Q4 		$601K Buy
+95,112
New +$927K 0.01% 1219

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

Kestra Advisory Services's CGTX Position: Q3 2025 in Review

Kestra Advisory Services sold out of Cognition Therapeutics (CGTX) in Q3 2025, closing a stake of 155,934 shares — an estimated $48.3K sold.

Kestra Advisory Services first reported a position in CGTX in Q4 2021 and held it in 15 quarters. The position peaked at $656K in Q1 2022. 69 funds tracked by Wall St. Rank hold CGTX as of Q3 2025.

  • Kestra Advisory Services reported no remaining Cognition Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Kestra Advisory Services sold 155,934 Cognition Therapeutics shares in Q3 2025, an estimated $48.3K.
  • Kestra Advisory Services first reported a position in Cognition Therapeutics in Q4 2021 and held it in 15 quarters.
  • Kestra Advisory Services's Cognition Therapeutics position peaked at $656K in Q1 2022.
  • 69 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q3 2025.

Based on Kestra Advisory Services's 13F filing for Q3 2025, filed 14 Nov 2025.